= Solution
\b[Invasion is a crucial enabling step for the natural dissemination of most solid <cancers>, but it is neither synonymous with <metastasis> nor sufficient to complete it.] A carcinoma must escape its original epithelial compartment and negotiate surrounding tissue before disseminated <biological cells> can form a distant lesion. An invasive primary <tumour> can nevertheless fail at circulation survival, distant tissue entry or colonization.
The <metastatic cascade> is a sequence of conditional transitions: local escape, access to blood or lymph, survival during transport, arrest and entry at a distant site, and successful outgrowth. Schematically,
$$
P(\mathrm{distant\ colony})=P(E)P(T\mid E)P(S\mid E,T)P(C\mid E,T,S),
$$
where $E$ is escape, $T$ transport, $S$ establishment of a surviving disseminated <biological cell> and $C$ sustained colonization. This is a chain of conditional probabilities, not an assumption that the stages are independent. An intervention can strongly affect one factor while leaving another limiting step dominant. Consequently, invasiveness and overall metastatic efficiency need not rank <tumour> populations identically.
Local invasion requires altered relationships with neighbouring <biological cells> and <extracellular matrix>. <cancer> <biological cells> may remodel matrix, traverse pre-existing paths or recruit stromal <biological cells> that facilitate movement. Adhesion changes, <actomyosin> forces, polarity and protease activity can contribute in different proportions depending on tissue geometry. Histological breach of a <basement membrane> is important evidence of invasive carcinoma, but a static section does not reveal whether the <tumour> <biological cell> itself degraded the barrier or exploited a route created by another <biological cell>. Intravital imaging, three-dimensional culture and perturbation of both <tumour> and stromal compartments help identify the mechanism.
Invasion does not require every <biological cell> to become an isolated mesenchymal migrant. <biological cells> can move collectively while maintaining junctions, with leader and follower <biological cells> performing different tasks. <organoid> and <tumour> experiments showed that basal-marker-positive leader <biological cells> can drive collective breast-cancer invasion, and functional perturbation of the programme impaired that behaviour.<Collective invasion in breast cancer requires a conserved basal epithelial program by Kevin J. Cheung and others>[Collective strands, leader-cell programme and perturbation]{ref} Such evidence links a specific invasion mechanism to tissue behaviour, while leaving open which additional properties allow those invading <biological cells> to form distant colonies.
An <epithelial-to-mesenchymal transition> can assist dissemination in some contexts, but <epithelial-to-mesenchymal transition> and invasion should not be treated as interchangeable variables. EMT-associated changes can alter motility, survival and therapy response; partial states can retain epithelial cohesion. In a breast-cancer lineage-tracing model, metastases occurred without passage through the reporter-defined <epithelial-to-mesenchymal transition> state, while that state was associated with chemoresistance.<Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance by Kari R. Fischer and others>[Lineage tracing, lung metastasis and treatment response]{ref} The inference is limited by the state the reporter detects: failure to mark a <biological cell> is not proof that no transient or partial transition occurred. Other experimental work found that the timing of <epithelial-to-mesenchymal transition> activation and reversal affected dissemination and metastatic growth, emphasizing that a useful escape programme can differ from a useful colonization programme.<Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis by Jeff H. Tsai and others>[Temporal manipulation of EMT and metastatic progression]{ref} These findings challenge a universal <epithelial-to-mesenchymal transition> requirement, not the requirement to cross relevant anatomical barriers.
A direct test of invasion's importance must preserve the stages being investigated. Start with an orthotopic primary <tumour> and inducibly perturb a proposed invasion factor after comparable <tumours> have formed. Quantify primary burden, local boundary crossing, circulating <biological cells>, early distant seeds and later colonies separately. A reduction in metastases accompanied by much smaller primaries could simply reflect fewer <biological cells> available to disseminate. Conversely, a perturbation that leaves growth unchanged but reduces escape and subsequent seeds supports an invasion-specific contribution. Rescue and independent perturbations help exclude nonspecific loss of viability or adhesion.
Intravenous injection is a complementary bypass experiment: it tests transport survival and later establishment while omitting much primary-site invasion and <intravasation>. If a mutant fails from a primary <tumour> but succeeds after injection, that supports an early-stage defect. If it fails in both assays, it may affect a later step or several processes. Injection is not a demonstration that invasion is dispensable for spontaneous <metastasis>. The route also changes the first capillary bed encountered and introduces an artificial bolus. Where feasible, temporally restricted perturbation, primary-tumour resection and tracking of individually labelled disseminated clones can further distinguish escape from dormancy and outgrowth.
The anatomical context matters. Blood <cancers> already occupy migratory compartments, so their dissemination cannot be forced into the same basement-membrane-escape model as an epithelial carcinoma. Within solid <cancers>, the rate-limiting step can also differ by organ and <tumour> state. \b[Invasion provides access to the metastatic route in most solid <tumours>; distant colonization is an additional, demanding phenotype. Its importance is established by stage-specific causal measurements, not by equating an invasion assay, an <epithelial-to-mesenchymal transition> marker or a vascular injection result with the whole metastatic process.]
Back to article page
